Literature DB >> 8770955

Apoptosis in glomerular sclerosis.

H Sugiyama1, N Kashihara, H Makino, Y Yamasaki, A Ota.   

Abstract

Glomerulosclerosis is characterized by progressive extracellular matrix accumulation and glomerular cell loss. The role of glomerular cell apoptosis in glomerulosclerosis was investigated in the rat remnant kidney model and in human glomerular diseases. We identified apoptotic cells in the glomeruli, tubules and interstitium in the remnant kidney by electron microscopy. DNA fragmentation, which is a biochemical characteristic of apoptosis, was detected by in situ nick end-labeling of fragmented DNA with terminal deoxynucleotidyl transferase and biotinylated deoxyuridine triphosphate. Fragmented DNA in the glomeruli and tubules increased with the progression of glomerulosclerosis in the remnant kidney model. This finding was also demonstrated in other glomerular sclerotic lesions such as IgA and lupus nephritis. The number of cells positive for nick end-labeling in the glomerulus significantly correlated with the degree of glomerulosclerosis and the deterioration of renal function. These results indicate that apoptosis is, at least in part, involved in the cell deletion of various glomerular diseases leading to sclerosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8770955     DOI: 10.1038/ki.1996.14

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  29 in total

Review 1.  Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.

Authors:  G Pugliese; F Pricci; G Romeo; G Leto; L Amadio; C Iacobini; U Di Mario
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

Review 2.  A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases.

Authors:  Nishkantha Arulkumaran; Robert J Unwin; Frederick Wk Tam
Journal:  Expert Opin Investig Drugs       Date:  2011-04-21       Impact factor: 6.206

3.  Ischaemic/reperfusion injury: Role of infliximab.

Authors:  Atul Bagul
Journal:  World J Transplant       Date:  2012-06-24

4.  Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo.

Authors:  Y Maeshima; N Kashihara; T Yasuda; H Sugiyama; T Sekikawa; K Okamoto; K Kanao; Y Watanabe; Y S Kanwar; H Makino
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

5.  The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis.

Authors:  T S Johnson; M Griffin; G L Thomas; J Skill; A Cox; B Yang; B Nicholas; P J Birckbichler; C Muchaneta-Kubara; A Meguid El Nahas
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

6.  Type IV collagen and laminin regulate glomerular mesangial cell susceptibility to apoptosis via beta(1) integrin-mediated survival signals.

Authors:  A Mooney; K Jackson; R Bacon; C Streuli; G Edwards; J Bassuk; J Savill
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

7.  Spironolactone inhibits apoptosis in rat mesangial cells under hyperglycaemic conditions via the Wnt signalling pathway.

Authors:  Dan Zhu; Hongwei Yu; Hongjiang He; Jiuli Ding; Jie Tang; Dan Cao; Lirong Hao
Journal:  Mol Cell Biochem       Date:  2013-04-29       Impact factor: 3.396

8.  Brain dead donor kidneys are immunologically active: is intervention justified?

Authors:  G Vergoulas; P Boura; G Efstathiadis
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

9.  T cells, adhesion molecules and modulation of apoptosis in visceral leishmaniasis glomerulonephritis.

Authors:  Francisco A L Costa; Maria G Prianti; Teresa C Silva; Silvana M M S Silva; José L Guerra; Hiro Goto
Journal:  BMC Infect Dis       Date:  2010-05-11       Impact factor: 3.090

10.  Glomerular cell apoptosis in human lupus nephritis.

Authors:  Hirofumi Makino; Hitoshi Sugiyama; Yasushi Yamasaki; Yohei Maeshima; Jun Wada; Naoki Kashihara
Journal:  Virchows Arch       Date:  2003-05-15       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.